Table 3.
Positive Association | Negative Association | ||||
---|---|---|---|---|---|
Cohort | Cox Coefficient | p-Value | Cohort | Cox Coefficient | p-Value |
DYSF EXPRESSION | |||||
CESC | 0.266 | 4.20e−02 | SARC | −0.277 | 1.00e−02 |
STAD | 0.171 | 4.80e−02 | KIRC | −0.220 | 1.00e−02 |
OTOF EXPRESSION | |||||
KIRC | 0.377 | 1.50e −06 | BLCA | −0.275 | 4.50e−04 |
KIRP | 0.413 | 4.90e−03 | SKCM | −0.169 | 1.40e−02 |
MYOF EXPRESSION | |||||
LGG | 0.441 | 1.40e −05 | SKCM | −0.163 | 1.90e−02 |
PAAD | 0.561 | 1.70e −05 | |||
LAML | 0.215 | 4.70e−02 | |||
FER1L4 EXPRESSION | |||||
KIRC | 0.356 | 5.20e −06 | BLCA | −0.383 | 2.90e −06 |
KIRP | 0.492 | 1.10e−03 | SKCM | −0.225 | 1.10e−03 |
LGG | 0.244 | 4.00e−03 | |||
FER1L5 EXPRESSION | |||||
LUAD | −0.199 | 1.30e−02 | |||
FER1L6 EXPRESSION | |||||
KIRC | −0.160 | 4.80e−02 | |||
READ | −0.401 | 4.90e−02 |
Ferlin gene expression from cohorts with cancer was submitted to a survival analysis with a Cox regression. The red rows indicate a negative Cox coefficient, the green rows indicate positive Cox coefficient. The bold p-values were considered as highly significant (p < 10−4). Bladder urothelial carcinoma (BLCA), cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), acute myeloid leukemia (LAML), brain lower grade glioma (LGG), lung adenocarcinoma (LUAD), pancreatic adenocarcinoma (PAAD), rectum adenocarcinoma (READ), sarcoma (SARC), skin cutaneous melanoma (SKCM), stomach adenocarcinoma (STAD).